Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center

• Główni autorzy: Megan Muldoon (Autor), Mollie Beck (Autor), Nichlas Sebree (Autor), Robin Yoder (Autor), Stacey Ritter (Autor), Josiah D. Allen (Autor), Zuhair Alqahtani (Autor), Jaime Grund (Autor), Brooke Philips (Autor), Kristina Hesse (Autor), Nihal El Rouby (Autor)
• Format: Książka
• Wydane: Wiley, 2024-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract We set out to demonstrate the feasibility of pharmacogenetic testing of DPYD and UGT1A1 and explore the clinical benefits in a community‐based cancer center. We conducted a retrospective review of 280 patients who underwent pharmacogenetic testing between November 2020 and May 2023. The pri...